Open App →
Back to News Feed
PR Newswire August 6, 2026 neutral

Biohaven Appoints Technology Investor John Yetimoglu to Board of Directors

AI / LLM
<p>Infinitum founder and Groq board director brings frontier AI and technology-investing expertise to Biohaven as the company advances AI-enabled approaches to drug development NEW HAVEN, Conn., Aug. 6, 2026 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN), a global biopharmaceutical company,...</p>
Read original article ↗